0.00Open0.03Pre Close0 Volume202 Open Interest79.00Strike Price0.00Turnover446.69%IV-1.79%PremiumDec 6, 2024Expiry Date1.47Intrinsic Value100Multiplier-4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.0800Delta0.1791Gamma2682.33Leverage Ratio-28.8435Theta0.0000Rho214.69Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet